Eli Lilly and Co said its boarddecided to sell Elizabeth Arden Inc, a wholly owned subsidiarythat manufactures and markets cosmetics and fine fragranceproducts.    It said the business, which had sales of 67 mln dlrs whenit was acquired in 1971, had sales last year of 398 mln dlrs,up 12 pct from 1985. It had operating profits of about 33 mlndlrs in 1986.    Lilly said it retained Morgan Stanley and Co to helpevaluate offers.    Lilly said it expects to use the after-tax proceeds fromthe sale of its cosmetics business for general corporatepurposes, including the repurchase from time to time of itscommon stock or warrants on the open market.    In a statement, Lilly Chairman Richard Wood said "Thisstrategic decision was reached on the basis of our belief thatin the future the corporation's resources, including itsresearch activities, should be focused on its other businesswhich have a high technology, life sciences orientation." Reuter&#3;